This site uses cookies. By continuing to browse the site without disabling them, you consent to our use of cookies. To learn more about the types of cookies we use, please view our cookie policy.

Indivior
  • Product Query or Adverse Event
  • Careers
  • Contact Us
  • Locations
  • International
  • About
    • History
    • Leadership
  • Diseases of Addiction
    • A Worldwide Crisis
    • The Patient Journey
  • R & D
    • Publications
    • White Papers
    • Abstracts
    • Grants
  • Products
  • Responsibility
    • Environment, Climate Change and Health and Safety
    • Communities
    • Patient Safety and Product Quality
    • Corporate Integrity Agreement
    • Integrity & Compliance
    • Business Conduct
    • People
    • Advocacy and Stakeholder Engagement
    • Transparency Program
  • Investors
  • Media
  • Investor Information
    • Annual Reports
    • Press Releases
    • RNS Filings
    • RNS Filings (Inside Information)
    • SEC Filings
    • Corporate Alert Service
    • Webcasts / Audiocasts / Presentations
    • Prospectus
    • Upcoming Events
    • Buprenorphine Market Modeling Methodology
  • Share Price
    • Share Price Center
    • Share Price Table
    • Historic Share Price
    • Share Price Calculator
    • Demerger: Base Cost
  • Corporate Governance
    • UK Corporate Governance Code
    • Leadership
    • The Board
    • Statements made under s430(2B) of the Companies Act 2006
    • Board Committees
    • Executive Committees
    • Risk Management and Internal Control
    • Indivior Integrity & Compliance Program
    • Integrity & Compliance
    • Corporate Responsibility
    • Tax Strategy
    • Global Conduct Policies
  • Shareholder Information
    • Managing Your Shareholding
    • Dividends
    • Annual General Meeting
    • American Depositary Receipts
  • Contact Us
  • Investor Information
    • Annual Reports
    • Press Releases
    • RNS Filings
    • RNS Filings (Inside Information)
    • SEC Filings
    • Corporate Alert Service
    • Webcasts / Audiocasts / Presentations
    • Prospectus
    • Upcoming Events
    • Buprenorphine Market Modeling Methodology
  • Share Price Information
    • Share Price Center
    • Share Price Table
    • Historic Share Price
    • Share Price Calculator
    • Demerger: Base Cost
  • Corporate Governance
    • UK Corporate Governance Code
    • Leadership
    • The Board
    • Statements made under s430(2B) of the Companies Act 2006
    • Board Committees
    • Executive Committees
    • Risk Management and Internal Control
    • Integrity & Compliance
    • Corporate Responsibility
    • Tax Strategy
    • Global Conduct Policies
  • Shareholder Information
    • Managing Your Shareholding
    • Dividends
    • Annual General Meeting
    • American Depositary Receipts
  • Contact Us

Investor Information

Latest News

  • Indivior FY 2020 Financial Results Presentation

    February 18, 2021

  • Indivior Announces FY 2020 Financial Results

    February 18, 2021 | PDF Version

  • Indivior Reaches Settlement with Reckitt Benckiser

    January 25, 2021 | PDF Version

  • The Department of Health and Human Services Announces New Guidance Intended to Expand Access to Medication-Assisted Treatment for the Treatment of Opioid Use Disorder

    January 15, 2021 | PDF Version

See more

Upcoming Events

  • FY 2020 Results Presentation

    Thursday, February 18th
  • See more

Webcasts/Audiocasts/Presentations

Click on the headings to view online or download a presentation:

  • Indivior FY 2020 Financial Results Presentation

  • Jefferies Virtual Global Healthcare Conference – November 17th – 12:00 PM US Eastern Time (ET)

  • Stifel Virtual Healthcare Conference – November 16th, 8:00 AM US Eastern Time (ET)

  • November 2020 Investor Presentation

  • Indivior Third Quarter and Nine Months Financial Results Presentation

  • See more

RNS Filings

RNS Filings

View Indivior filings with the Regulatory News Service on regulatory and non-regulatory updates.

See more

Annual Reports

Analytics_and_Forecast

View Indivior Annual Reports

See more

  • About
  • Diseases of Addiction
  • R & D
  • Products
  • Responsibility
  • Investors
  • Media
  • MODERN SLAVERY STATEMENT (PDF)
  • Product Query or Adverse Event
  • Careers
  • Contact
  • Terms of Use
  • Privacy Policy
  • Accessibility
  • Privacy Policy and Notice for California Residents
  • International

© 2020 Indivior PLC | INDIVIOR is a registered trademark of Indivior UK Limited.

You are now leaving Indivior.com to visit Suboxone.com a US product site intended for US residents and healthcare professionals.

Continue    Return

You are now leaving Indivior.com.

Continue    Return

You are about to leave the Indivior website

The product specific Internet site that you have requested is intended for US audiences, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or regions.

Do you wish to continue to this product-specific site?

YES
I agree
NO
I disagree